4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-19-053259
Chairman and CEO bought 19,100 shares at an average $2.58 ($49,370)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2019-10-14 | Purchase | +8,800 | $2.45 | $21,560 | 10,242,093 | D |
| Niihara Yutaka Chairman and CEO | 2019-10-15 | Purchase | +10,300 | $2.70 | $27,810 | 10,252,393 | D |
| Open-market purchases · 19,100 sh · avg $2.58 · $49,370 | |||||||
Loading xslF345X03/doc4.xml…